Business
DarioHealth Announces Two New Contracts within the Employer and Provider Markets
Dario now counts more than 50 clients across multi-chronic condition platform solutions NEW YORK, Dec. 2, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq:
About this update from Dariohealth Corp.
[{"type":"text","content":"Dario now counts more than 50 clients across multi-chronic condition platform solutions\n\n\nNEW YORK, Dec. 2, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a regional employer contract for behavioral health, and a strategic partnership in the provider market that will allow Dario solutions to be sold through a network of practices across the United States. The two new contracts mark a key milestone for Dario, bringing its total signed clients to date to more than 50.\nDario's digital therapeutic platform provides proven support for people living with diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health needs by addressing the underlying health behaviors with a combination of innovative technologies, digital tools and expert human support. Each solution is fully integrated into a single AI-driven behavior change engine informed by billions of data points collected over ten years of consumer engagement to create a holistic, seamless member experience proven to deliver sustainable engagement and results.\n\"Achieving more than 50 signed contracts is something to celebrate after a year of positioning for success in the Business-to-Business (B2B) market. We are also thrilled to be heading into the new year with a robust footprint in the employer market alongside another strategic relationship to help accelerate expansion in the provider market,\" said Rick Anderson, President and General Manager North America.\nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.\nDario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, int...